Hypothalamic-pituitary-adrenal (HPA) axis suppression following topical application. Do not exceed the usual dose. Do not apply occlusive dressings to areas of clobetasol propionate application. Possible visual disturbance; consider referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma, or rare diseases (eg, central serous chorioretinopathy). Not to be used extensively during pregnancy (ie, large amounts or for prolonged periods). Lactation.
Sign Out
